Delivery Order SPE2DB25D3504-SPE2DB26FVTFK
- Not listed
- The Defense Logistics Agency awarded a $2,852.85 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 3 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $2,735.42 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 22, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a $2,548.11 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors in 0.5 ml dosage units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No set-aside provisions were applied to this procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,252.25. This non-competitive delivery order, utilizing firm fixed pricing, represents a discrete pharmaceutical procurement under AmerisourceBergen's broader relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a $26,135.43 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on September 2, 2025, with completion expected by September 3, 2025. This contract is issued under a firm fixed-price arrangement with no set-aside designation, representing a competitively awarded delivery order. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its...
- The Defense Logistics Agency awarded a $2,005.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on June 20, 2025, with completion scheduled for June 23, 2025. This non-set-aside contract represents a small-value pharmaceutical supply delivery to support federal medical procurement needs. The award was made to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injections, valued at $1,181.90, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB26FVTFKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,334.91 to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 20, 2025. AmerisourceBergen Drug Corp will perform from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of medications, including specialty pharmaceuticals, brand-name and generic drugs, and medical supplies to support military healthcare programs worldwide. The current delivery order for Trulicity, a diabetes medication, exemplifies the company's role in supplying critical pharmaceutical products to the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 10/17/25 |